自闭症谱系障碍
自闭症
神经科学
心理学
保健品
医学
发展心理学
病理
作者
Fernando Dobrachinski,Kátia Alves Ribeiro,Iverson Conrado Bezerra,Artur José da Silva,Camila Milagres Macedo Pereira,Kelle Vellasques,Heloísa Aiolfi Padilha,Sandra Elisa Haas,Daiana Silva Ávila,Priscila Gubert
标识
DOI:10.1016/j.bbr.2025.115653
摘要
The Autism Spectrum Disorder (ASD) is a neurodevelopmental condition that has been increasing in prevalence and is characterized by some degree of difficulty with social interaction, communication, and sensory response. According to the World Health Organization, ASD affects 1 in 100 children, and many factors may cause brain alterations, such as genetic and environmental factors. Currently, there is no standard treatment for ASD. Notably, one of the hallmarks of this condition is neuroinflammation since it has been suggested that autism results from central nervous system derangements due to chronic inflammatory reactions, with activation of microglial cells. Therefore, antioxidant and anti-inflammatory compounds may be nutraceutical supplements of interest to attenuate the impacts of neuroinflammation in ASD subjects. This review highlights the main molecules that have been successful in preclinical and clinical trials, as well as potential associations that might be further strategies to investigate.
科研通智能强力驱动
Strongly Powered by AbleSci AI